Jones; Sian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jones; Sian.The latest application filed is for "genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma".

Company Profile

9.18.28

Jones; Sian - Newbury Park CA
Jones; Sian - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for preparing AMG 416 (etelcalcetide) Grant 11,377,474 - Bezemer , et al. July 5, 2	2022-07-05
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma App 20210317532 - Vogelstein; Bert ; et al.	2021-10-14
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma Grant 10,894,987 - Vogelstein , et al. January 19, 2	2021-01-19
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma Grant 10,837,064 - Vogelstein , et al. November 17, 2	2020-11-17
Consensus coding sequences of human breast and colorectal cancers Grant 10,787,712 - Sjoblom , et al. September 29, 2	2020-09-29
Consensus Coding Sequences of Human Breast and Colorectal Cancers App 20200239970 - SJOBLOM; Tobias ; et al.	2020-07-30
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma Grant 10,704,108 - Vogelstein , et al.	2020-07-07
Consensus Coding Sequences of Human Breast and Colorectal Cancers App 20200048719 - SJOBLOM; Tobias ; et al.	2020-02-13
Method For Preparing Amg 416 (etelcalcetide) App 20190352336 - BEZEMER; Jeroen ; et al.	2019-11-21
Method for preparing AMG 416 Grant 10,407,464 - Bezemer , et al. Sept	2019-09-10
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma App 20190106752 - Vogelstein; Bert ; et al.	2019-04-11
Arid1a And Ppp2r1a Mutations In Cancer App 20180327863 - Vogelstein; Bert ; et al.	2018-11-15
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma App 20180282821 - Vogelstein; Bert ; et al.	2018-10-04
ARID1A and PPP2R1A mutations in cancer Grant 9,982,304 - Vogelstein , et al. May 29, 2	2018-05-29
Systems And Methods For Analyzing Nucleic Acid App 20180119230 - Velculescu; Victor ; et al.	2018-05-03
Consensus Coding Sequences of Human Breast and Colorectal Cancers App 20170362659 - SJOBLOM; Tobias ; et al.	2017-12-21
Method For Preparing Amg 416 App 20170190739 - BEZEMER; Jeroen ; et al.	2017-07-06
Medulloblastoma genes as targets for diagnosis and therapeutics Grant 9,695,479 - Vogelstein , et al. July 4, 2	2017-07-04
Genetic Alterations in Isocitrate Dehydrogenase and Other Genes in Malignant Glioma App 20170081730 - Vogelstein; Bert ; et al.	2017-03-23
Consensus coding sequences of human breast and colorectal cancers Grant 9,551,037 - Sjoblom , et al. January 24, 2	2017-01-24
Systems And Methods For Analyzing Nucleic Acid App 20160273049 - Velculescu; Victor ; et al.	2016-09-22
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma Grant 9,353,418 - Vogelstein , et al. May 31, 2	2016-05-31
Diagnostic method using PALB2 Grant 9,315,868 - Vogelstein , et al. April 19, 2	2016-04-19
Diagnostic Method Using PALB2/US App 20160032406 - Vogelstein; Bert ; et al.	2016-02-04
Consensus Coding Sequences of Human Breast and Colorectal Cancers App 20150167095 - SJOBLOM; Tobias ; et al.	2015-06-18
Genomic Landscapes of Human Breast and Colorectal Cancers App 20140377754 - WOOD; Laura D. ; et al.	2014-12-25
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma App 20140187764 - VOGELSTEIN; Bert ; et al.	2014-07-03
Consensus coding sequences of human breast and colorectal cancers Grant 8,741,573 - Sjoblom , et al. June 3, 2	2014-06-03
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma Grant 8,685,660 - Vogelstein , et al. April 1, 2	2014-04-01
Medulloblastoma Genes As Targets For Diagnosis And Therapeutics App 20130296408 - Vogelstein; Bert ; et al.	2013-11-07
ARID1A and PPP2R1A Mutations in Cancer App 20130210900 - Vogelstein; Bert ; et al.	2013-08-15
Genomic Landscapes Of Human Breast And Colorectal Cancers App 20130196312 - WOOD; Laura D. ; et al.	2013-08-01
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma App 20120202207 - VOGELSTEIN; Bert ; et al.	2012-08-09
Pathways Underlying Pancreatic Tumorigenesis and an Hereditary Pancreatic Cancer Gene App 20120115735 - Vogelstein; Bert ; et al.	2012-05-10
Diagnostic Method Using Palb2 App 20120034318 - Vogelstein; Bert ; et al.	2012-02-09
Genetic Alterations In Isocitrate Dehydrogenase And Other Genes In Malignant Glioma App 20110229479 - Vogelstein; Bert ; et al.	2011-09-22
Consensus Coding Sequences Of Human Breast And Colorectal Cancers App 20100316995 - Sjoblom; Tobias ; et al.	2010-12-16
Genomic Landscapes of Human Breast and Colorectal Cancers App 20090123928 - Wood; Laura D. ; et al.	2009-05-14

Company Registrations

NCAGE Code	78CD2	JONES, SIAN!DBA ART CONSERVATION SERVICES!DIV SIAN B JONES
CAGE Code	78CD2	JONES, SIAN ART CONSERVATION SERVICES SIAN B JONES
S.A.M. Registration	78CD2 [167428507]	JONES, SIAN ART CONSERVATION SERVICES

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.